Altasciences’ CNS Center of Excellence is globally renowned for offering expert, fully integrated early phase drug development services. Whether large or small molecule, our streamlined solutions can help move your compound from prototype formulation through to commercialization, delivering up to 40% in time savings.

Our in-house preclinical, clinical, bioanalytical, and manufacturing teams have completed over 200 neurological studies to date. By partnering with us, you benefit from:

•    a CNS research team comprised of neuroscientists, clinicians, psychiatrists, pharmacists, and other interdisciplinary experts;
•    a dedicated preclinical facility with expertise in cell and gene therapy;
•    three state-of-the-art clinical research sites;
•    10 on-site driving simulators for cognitive testing; and
•    300+ scientists for bioanalytical support.

And there’s more! Discover our full range of CNS drug development services here.

 Questions? Contact one of our experts.

Related resources that may interest you:

Scientific Journal: Integrated CNS Drug Development Solutions Lessen Complexities
Webinar: Practical Approaches When Conducting Clinical Trials With Psychedelics
Educational Video: Development Strategies for Neurological Drugs

The process of biologic drug development, from lead molecule identification to approval, can be long and complicated. Altasciences is here to help streamline the process. From discovery to preclinical, clinical, and beyond, Altasciences accelerates decision-making by offering expert guidance and synchronized early phase services to reduce timelines by up to 40%. With Altasciences, your entire program is managed by one organization and overseen by a single, cross-functional program manager to quickly and seamlessly advance your large molecule, and help you get your therapies to the people who need them, faster.

Download now.

You may also be interested in the following:
- Blog: Four Key Steps to Optimizing a Large Molecule Bioanalytical Program.
- Fact Sheet: Biologics/Biosimilars.
- Video: Quick Chat with Dr. Lynne Le Sauteur – The Benefits of Large Molecule Bioanalysis with Altasciences.

From Discovery to Market, We’ve Got You Covered.

As a leading partner in ophthalmic drug development, Altasciences has an outstanding track record formulating, testing, and manufacturing ophthalmic products. Working in tandem with our in-house preclinical, clinical, and bioanalytical teams, we ensure your compound advances safely and rapidly through each phase of drug development―from lead candidate selection to market.

Benefit from integrated CRO/CDMO services and a team that offers: 

•    Development and analytical testing of ophthalmic drug products in various dosage forms at our cGMP manufacturing facility
•    50 years of preclinical experience in ophthalmic safety testing
•    Three North American clinical research sites with over 500 beds and a database of 400,000+ participants
•    Bioanalytical expertise with rare and limited matrices, such as tears

Explore our full range of ophthalmic drug development services, or read the issue of The Altascientist to learn about the key considerations in each phase of ophthalmic drug development, including case studies.

Have questions? Consult with one of our experts. 

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Comprehensive Ophthalmic Drug Development Solutions

As an industry leader in ophthalmic drug development and research, our integrated CRO/CDMO solutions allow you to work with a single partner as your ocular compound advances from prototype formulation to preclinical testing through to early phase clinical trials and manufacturing.

Discover how Altasciences' end-to-end ophthalmic drug development solutions can help reduce your timelines by up to 40%!

Have questions? Consult with one of our experts.

You may also be interested in:

• Scientific Journal: Navigating the Complexities of Ophthalmic Drug Development
• Webpage: Clinical, Preclinical, Bioanalytical, and Manufacturing Services
• Webinar: Terminal Sterilization of Pharmaceutical Products

CNS Center of Excellence

Are you working on a CNS-active drug? With over 25 years of conducting preclinical and clinical studies, Altasciences’ CNS Center of Excellence experts have developed an extensive resource library, including webinars and scientific journals, to guide you through all phases of early drug development, from lead candidate selection to clinical proof of concept, and beyond.

The process from lead molecule identification to completion of a first‑in‑human trial can be long and complicated. But with Altasciences’ Proactive Drug Development solution, your timelines can be reduced by up to 40%. Your entire program will be managed by one organization and overseen by a single, cross-functional program manager to quickly and seamlessly advance your molecule from preclinical testing to first‑in‑human clinical trials, and beyond—helping you get your medicines to the people who need them, faster.

Learn more by downloading our eBook.

Altasciences keeps you on track, milestone to milestone.

Avoid delays caused by operational roadblocks, miscommunications, and lack of data sharing. 

Discover a simpler way to drug development success and how Altasciences’ integrated end-to-end CRO/CDMO solutions can safely move your molecule seamlessly from one phase to the next, and to market faster.

Start Watching!

Got 5 more minutes? Check out: 

• Webpage: Our Full Array of Drug Development, Manufacturing, and Analytical Solutions
• Scientific Paper: Benefits of Liquid-Filled Capsules Versus Tablets in Pharmaceutical Development

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.